Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis

Ryu Watanabe; Tomonori Ishii; Kyoko Araki; Mariko Ishizuka; Yukiko Kamogawa; Yoko Fujita; Yuko Shirota; Hiroshi Fujii; Hideo Harigae

doi:10.3109/14397595.2015.1012797

Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis

Ryu Watanabe, Tomonori Ishii, Kyoko Araki, Mariko Ishizuka, Yukiko Kamogawa, Yoko Fujita, Yuko Shirota, Hiroshi Fujii, Hideo Harigae

研究成果: Letter › 査読

13 被引用数 (Scopus)

本文言語	English
ページ（範囲）	465-466
ページ数	2
ジャーナル	Modern Rheumatology
巻	26
号	3
DOI	https://doi.org/10.3109/14397595.2015.1012797
出版ステータス	Published - 2016 5月 3

ASJC Scopus subject areas

リウマチ学

文献へのアクセス

10.3109/14397595.2015.1012797

他のファイルとリンク

引用スタイル

Watanabe, R., Ishii, T., Araki, K., Ishizuka, M., Kamogawa, Y., Fujita, Y., Shirota, Y., Fujii, H., & Harigae, H. (2016). Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis. Modern Rheumatology, 26(3), 465-466. https://doi.org/10.3109/14397595.2015.1012797

Watanabe, R, Ishii, T, Araki, K, Ishizuka, M, Kamogawa, Y, Fujita, Y, Shirota, Y, Fujii, H & Harigae, H 2016, 'Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis', Modern Rheumatology, vol. 26, no. 3, pp. 465-466. https://doi.org/10.3109/14397595.2015.1012797

@article{50b952e3ebc64542b83aede409f81134,

title = "Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis",

keywords = "Clinically amyopathic dermatomyositis, Interstitial lung disease, Multi-target therapy, Rituximab",

author = "Ryu Watanabe and Tomonori Ishii and Kyoko Araki and Mariko Ishizuka and Yukiko Kamogawa and Yoko Fujita and Yuko Shirota and Hiroshi Fujii and Hideo Harigae",

year = "2016",

month = may,

day = "3",

doi = "10.3109/14397595.2015.1012797",

language = "English",

volume = "26",

pages = "465--466",

journal = "Japanese Journal of Rheumatology",

issn = "1439-7595",

publisher = "Springer Japan",

number = "3",

}

TY - JOUR

T1 - Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis

AU - Watanabe, Ryu

AU - Ishii, Tomonori

AU - Araki, Kyoko

AU - Ishizuka, Mariko

AU - Kamogawa, Yukiko

AU - Fujita, Yoko

AU - Shirota, Yuko

AU - Fujii, Hiroshi

AU - Harigae, Hideo

PY - 2016/5/3

Y1 - 2016/5/3

KW - Clinically amyopathic dermatomyositis

KW - Interstitial lung disease

KW - Multi-target therapy

KW - Rituximab

UR - http://www.scopus.com/inward/record.url?scp=84964319873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964319873&partnerID=8YFLogxK

U2 - 10.3109/14397595.2015.1012797

DO - 10.3109/14397595.2015.1012797

M3 - Letter

C2 - 25698368

AN - SCOPUS:84964319873

SN - 1439-7595

VL - 26

SP - 465

EP - 466

JO - Japanese Journal of Rheumatology

JF - Japanese Journal of Rheumatology

IS - 3

ER -